Abstract:Objective To explore the mechanism of nitidine chloride on promoting apoptosis of myeloma cells.Methods Multiple myeloma (MM) cell lines RPMI 8226 were cultured to the logarithmic phase, and the cell viability and the half-maximal inhibitory concentration (IC50) were detected via the CCK8 assay. RPMI 8226 cells were randomly divided into blank group, bortezomib (BTZ) group, nitidine chloride (NCe) group and BTZ + NCe group. The cells in the BTZ group, Nce group and the BTZ + NCe group were then cultured for another 24 hours in the presence of 500 μL 10 nmol/L of BTZ, 500 μL 4.5 μmol/L of NCe according to the IC50, and 250 μL 10 nmol/L of BTZ plus 250 μL 4.5 μmol/L of NCe, respectively. Annexin V-FITC/PI double labeling was performed to measure the cell apoptosis, while quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting were applied to detect the relative mRNA and protein expressions of STK4, YAP1, and Cl-caspase-3 in each group, respectively.Results Compared with the blank wells, the cell survival rates of other wells decreased (P < 0.05). Compared with the wells without NCe, the cell survival rates of wells with 1 μmol/L, 2 μmol/L, 4 μmol/L and 8 μmol/L of NCe also decreased (P < 0.05), and the IC50 at 24 h of culture was (4.56 ± 0.64) μmol/L. Compared with the blank group, the apoptosis rates were higher, the relative mRNA and protein expressions of STK4 were lower (P < 0.05), and the relative mRNA and protein expressions of YAP1 and Cl-caspase-3 were higher in the BTZ group, NCe group and BTZ + NCe group (P < 0.05).Conclusions Nitidine chloride can inhibit the proliferation of myeloma cells and promote their apoptosis, which may be achieved by regulating the STK4/YAP1 pathway.